Actively Recruiting
Randomized Study of a Dematerialized Management for Post-Emergency Gynecological Follow-Up
Led by Assistance Publique - Hôpitaux de Paris · Updated on 2026-04-21
200
Participants Needed
1
Research Sites
108 weeks
Total Duration
On this page
Sponsors
A
Assistance Publique - Hôpitaux de Paris
Lead Sponsor
U
URC-CIC Paris Descartes Necker Cochin
Collaborating Sponsor
AI-Summary
What this Trial Is About
The GYNAB study aims to compare patient satisfaction and clinical outcomes between dematerialized post-emergency gynecological follow-up using a connected health app and traditional in-person follow-up. Conducted by Drs. Laëtitia CAMPIN and Louis MARCELLIN at Hôpital Cochin, it is sponsored by Assistance Publique - Hôpitaux de Paris. The main objective is to assess patient satisfaction at day 7 on a scale from 0 to 10, considering symptom management, follow-up quality, and task performance. Secondary objectives include comparing satisfaction at day 28, PROM-ED scores for symptom relief, understanding, reassurance, and care planning at days 7 and 28, hospitalization rates, unscheduled consultations, surgical interventions, total hospital time by day 28, and physician satisfaction at 28 days. This randomized trial involves women aged 18-60 needing follow-up for conditions like genital infections, non-complicated ectopic pregnancies, unlocated pregnancy, first trimester metrorrhagia, miscarriages , and severe vomiting before 12 weeks. Inclusion criteria are women aged 18-60 needing specified follow-up. Exclusion criteria are severe clinical intolerance, severe criteria ultrasound findings, non-French speakers, and inability to use digital applications. The intervention group uses a connected health app for data collection and communication, logging symptoms and test results, with medical team notifications for urgent updates. The control group receives traditional in-person follow-up with scheduled consultations and emergency contact information. The study hypothesizes that digital follow-up will improve patient experience, reduce hospital visits, and provide comparable or superior satisfaction and clinical outcomes. The results could promote broader digital health adoption in various medical fields.
CONDITIONS
Official Title
Randomized Study of a Dematerialized Management for Post-Emergency Gynecological Follow-Up
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Women aged 18 to 60 years
- No consultation at the gynecological emergency department in the previous month and/or for the same pregnancy
- Requires post-emergency follow-up for one of the following conditions: genital infections needing antibiotics, non-complicated ectopic pregnancy without rupture or significant ultrasound findings, early pregnancy with uncertain viability and low bHCG, missed miscarriage treated with Misoprostol, moderate first trimester vaginal bleeding without instability, or severe vomiting before 12 weeks without severe criteria
You will not qualify if you...
- Severe clinical intolerance defined by signs of severe sepsis, abdominal defense or contracture, uncontrolled pain, severe dehydration, total food intolerance due to vomiting, or uncontrolled active hemorrhage
- Significant ultrasound findings including tubo-ovarian abscess ≥ 3 cm or significant intra-abdominal effusion
- Non-French speaking patients
- Inability to download or use the digital application due to isolated or precarious digital circumstances
- Refusal to sign consent form
- Patients under legal guardianship or court protection
- Patients not affiliated with a social security system
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
Hôpital Cochin
Paris, France, 75014
Actively Recruiting
Research Team
L
Laetitia CAMPIN, MD
CONTACT
V
Valérie PLENCE
CONTACT
How is the study designed?
Study Type
INTERVENTIONAL
Masking
NONE
Allocation
RANDOMIZED
Model
PARALLEL
Primary Purpose
SUPPORTIVE_CARE
Number of Arms
2
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here